SIK2 and ovarian carcinoma: Salt-inducible kinase 2 (SIK2) overexpression in ovarian cancer cells activates the PI3K/AKT/HIF-1α pathway, upregulates HIF-1α expression, directly upregulates the transcription of major glycolytic genes and promotes glycolysis (123).